coenzyme-q10 and Asthma

coenzyme-q10 has been researched along with Asthma* in 3 studies

Reviews

1 review(s) available for coenzyme-q10 and Asthma

ArticleYear
Obesity, metabolic syndrome, and airway disease: a bioenergetic problem?
    Immunology and allergy clinics of North America, 2014, Volume: 34, Issue:4

    Multiple studies have determined that obesity increases asthma risk or severity. Metabolic changes of obesity, such as diabetes or insulin resistance, are associated with asthma and poorer lung function. Insulin resistance is also found to increase asthma risk independent of body mass. Conversely, asthma is associated with abnormal glucose and lipid metabolism, insulin resistance, and obesity. Here we review our current understanding of how dietary and lifestyle factors lead to changes in mitochondrial metabolism and cellular bioenergetics, inducing various components of the cardiometabolic syndrome and airway disease.

    Topics: Asthma; Bronchial Hyperreactivity; Caloric Restriction; Energy Metabolism; Exercise; Humans; Metabolic Syndrome; Mitochondria; Molecular Targeted Therapy; Obesity; Organophosphorus Compounds; Ubiquinone

2014

Trials

1 trial(s) available for coenzyme-q10 and Asthma

ArticleYear
Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma.
    BioFactors (Oxford, England), 2005, Volume: 25, Issue:1-4

    Bronchial asthma is a chronic inflammatory disease of respiratory system, with disturbances in the dynamic balance of oxidant-antioxidant capacity of the lungs. Long-term administration of corticosteroids has been shown to result in mitochondrial dysfunction and oxidative damage of mitochondrial and nuclear DNAs. We previously documented decreased coenzyme Q(10) (CoQ(10)) and alpha-tocopherol concentrations in plasma and blood in corticosteroid-dependent bronchial asthma patients. In the present study we demonstrate that CoQ(10) supplementation reduces the dosage of corticosteroids in these patients.. This was an open, cross-over, randomized clinical study with 41 bronchial asthma patients (13 males, 28 females), ages 25-50 years. All patients suffered from persistent mild to moderate asthma. The patients were divided into two groups, one group receiving standard antiasthmatic therapy and clinically stabilized, and the second group receiving, in addition, antioxidants consisting of CoQ(10) as Q-Gel (120 mg) + 400 mg alpha-tocopherol + 250 mg vitamin C a day. The groups were crossed over at 16 weeks for a total duration of 32 weeks.. Data show that patients with corticosteroid-dependent bronchial asthma have low plasma CoQ(10) concentrations that may contribute to their antioxidant imbalance and oxidative stress. A reduction in the dosage of corticosteroids required by the patients following antioxidant supplementation was observed, indicating lower incidence of potential adverse effects of the drugs, decreased oxidative stress. This study also demonstrates the significant uptake of CoQ(10) by lung tissue in a rat model using hydrosoluble CoQ(10) (Q-Gel).

    Topics: Adrenal Cortex Hormones; Adult; alpha-Tocopherol; Animals; Ascorbic Acid; Asthma; Coenzymes; Cross-Over Studies; Female; Humans; Lung; Male; Middle Aged; Mitochondria; Rats; Rats, Wistar; Ubiquinone

2005

Other Studies

1 other study(ies) available for coenzyme-q10 and Asthma

ArticleYear
Decreased levels of coenzyme Q(10) in patients with bronchial asthma.
    Allergy, 2002, Volume: 57, Issue:9

    The contribution of free oxygen radicals in the pathogenesis of bronchial asthma is generally accepted. The modulation of antioxidative defence by supplementation with antioxidants represents additive therapy in complex management of disease. The aim of the study was to assess the levels of coenzyme Q10, alpha-tocopherol, and beta-carotene both in plasma and whole blood, and malondialdehyde (MDA) and eosinophil cationic protein (ECP) in plasma of asthmatics (As).. Fifty-six As (15 males and 41 females) aged from 19 to 72 years (mean age 46 years) suffering from allergic asthma were enrolled into the study. The control group comprised 25 healthy volunteers (16 males, 9 females) aged 25-50 years.. The concentrations of CoQ10 decreased significantly both in plasma and whole blood, compared with healthy volunteers (0.34 +/- 0.15 micromol/l vs. 0.52 +/- 0.15 micromol/l, 0.33 +/- 0.14 micromol/l vs. 0.50 +/- 0.13 micromol/l, P < 0.001, P< 0.001, respectively). The levels of alpha-tocopherol were decreased both in plasma and whole blood in comparison with controls [24.10 micromol/l (19.8; 30.5), vs. 33.20 micromol/l (28.25; 38.05), 17.22 +/- 6.45 micromol/l vs. 21.58 +/- 7.92 micromol/l, P= 0.006, P = 0.01, respectively]. The levels of MDA were elevated over the reference range in both groups (reference range < 4.5 micromol/l). No changes were seen in beta-carotene concentrations. Positive correlation was found between whole blood CoQ10 and alpha-tocopherol concentrations.. Results of the study suggest a possible contribution of suboptimal concentrations of CoQ10 on antioxidative dysbalance in As and provide a rationale for its supplementation.

    Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Asthma; beta Carotene; Blood Proteins; Coenzymes; Eosinophil Granule Proteins; Female; Humans; Inflammation Mediators; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Ribonucleases; Ubiquinone

2002